Skip to main content
TipRanks
Go Ultimate75% OFF

Kazia Therapeutics (KZIA) Ownership - Who Owns Kazia Therapeutics?

341 Followers

Kazia Therapeutics (KZIA) Ownership Overview

  • 0.04% Mutual Funds
  • 38.88% Other Institutional Investors
  • 0.08% ETFs
  • 61.01% Public Companies and Individual Investors

The ownership structure of Kazia Therapeutics (KZIA) stock is a mix of institutional, retail, and individual investors. Approximately 38.99% of the company’s stock is owned by Institutional Investors, and 61.01% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

KZIA top shareholders
Holder# of SharesType% HoldingValue
Activepassive8,865Institution0.08%48,669
Fidelity Concord Street Trust4,237Institution0.04%23,261

Top Mutual Fund Holders

KZIA top mutual fund holders
Holder# of SharesType% HoldingValue
Fidelity Concord Street Trust4,237Institution0.04%23,261

Top ETF Holders

KZIA top ETF holders
Holder# of SharesType% HoldingValue
ActivePassive International Equity ETF, APIE ETF8,865Institution0.08%47,073

FAQ

What percentage of Kazia Therapeutics (KZIA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.99% of Kazia Therapeutics (KZIA) stock is held by institutional investors: 0.04% by mutual funds, 0.08% by ETFs and 38.88% by other institutional investors.
What percentage of Kazia Therapeutics (KZIA) stock is held by retail investors?
According to the latest TipRanks data, approximately 61.01% of Kazia Therapeutics (KZIA) stock is held by public companies and individual investors.
Who owns the most shares of Kazia Therapeutics (KZIA)?
ActivePassive owns the most shares of Kazia Therapeutics (KZIA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.